Report cover image

Generics Top 5 Emerging Markets Industry Guide 2019-2028

Publisher MarketLine
Published Dec 20, 2024
Length 234 Pages
SKU # MTLN19599836

Description

Generics Top 5 Emerging Markets Industry Guide 2019-2028Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • These countries contributed $1,61,156.7 million to the global generics industry in 2023, with a compound annual growth rate (CAGR) of 12.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $2,33,053.5 million in 2028, with a CAGR of 7.7% over the 2023-28 period.
  • Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $1,21,016.7 million in 2023. This was followed by India and Brazil with a value of $22,824.0 and $9,214.4 million, respectively.
  • China is expected to lead the generics industry in the top five emerging nations, with a value of $1,77,196.9 million in 2028, followed by India and Brazil with expected values of $31,455.5 and $14,400.1 million, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
  • Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
  • What was the size of the emerging five generics market by value in 2023?
  • What will be the size of the emerging five generics market in 2028?
  • What factors are affecting the strength of competition in the emerging five generics market?
  • How has the market performed over the last five years?
  • How large is the emerging five generics market in relation to its regional counterparts?

Table of Contents

234 Pages
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Generics
2.1. Industry Outlook
3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Teva Pharmaceutical Industries Ltd
13.2. Viatris Inc
13.3. Sun Pharmaceutical Industries Ltd
13.4. Novartis AG
13.5. Sandoz Group AG
13.6. Hikma Pharmaceuticals Plc
13.7. Sanofi
13.8. Les Laboratoires Servier SAS
13.9. Stada Arzneimittel AG
13.10. Bayer AG
13.11. Lupin Ltd
13.12. Aspen Pharmacare Holdings Ltd
13.13. EMS SA
13.14. Eurofarma Laboratorios SA
13.15. Ache Laboratorios Farmaceuticos SA
13.16. Apotex Inc
13.17. Teva Canada Ltd
13.18. Sandoz Canada Inc
13.19. CSPC Pharmaceutical Group Ltd
13.20. Sino Biopharmaceutical Ltd
13.21. Hansoh Pharmaceutical Group Co Ltd
13.22. Dr. Reddy's Laboratories Ltd
13.23. Cipla Ltd
13.24. Aurobindo Pharma Ltd
13.25. PT Kalbe Farma Tbk
13.26. PT Indofarma Tbk
13.27. PT Sanbe Farma
13.28. PT Soho Global Health Tbk
13.29. Friulchem SpA
13.30. DOC Generici SRL
13.31. Recordati SpA
13.32. Daiichi Sankyo Co Ltd
13.33. Towa Pharmaceutical Co Ltd
13.34. Sawai Group Holdings Co Ltd
13.35. Toho Holdings Co Ltd
13.36. Laboratorios Silanes SA de CV
13.37. Pfizer Inc
13.38. Biocad
13.39. R-Pharm
13.40. Pharmstandard
13.41. AstraZeneca Plc
13.42. Bluefish Pharmaceuticals AB
13.43. Navamedic ASA
13.44. Novartis International AG
13.45. Beacons Pharmaceuticals Pte Ltd
13.46. Abbott Laboratories SA
13.47. Adcock Ingram Holdings Ltd
13.48. Dongkook Pharmaceutical Co Ltd
13.49. JW Holdings Corp
13.50. Hanmi Pharmaceuticals Co Ltd
13.51. Dong Wha Pharma Co Ltd
13.52. Esteve Pharmaceuticals SA
13.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
13.54. Deva Holding AS
13.55. Sandoz Inc
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2019-28
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2019-23
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2023-28
Table 4: South Africa generics market value: $ million, 2018-23
Table 5: South Africa generics market volume: % of total pharma volume, 2018-23
Table 6: South Africa generics market geography segmentation: $ million, 2023
Table 7: South Africa generics market value forecast: $ million, 2023-28
Table 8: South Africa generics market volume forecast: % of total pharma volume, 2023-28
Table 9: South Africa Size of Population (million), 2019-23
Table 10: South Africa real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 11: South Africa GDP (Current Prices, $ Billion), 2019-23
Table 12: South Africa Inflation, 2019-23
Table 13: South Africa Consumer Price Index (Absolute), 2019-23
Table 14: South Africa exchange rate, 2018-23
Table 15: Brazil generics market value: $ million, 2018-23
Table 16: Brazil generics market volume: % of total pharma volume, 2018-23
Table 17: Brazil generics market geography segmentation: $ million, 2023
Table 18: Brazil generics market value forecast: $ million, 2023-28
Table 19: Brazil generics market volume forecast: % of total pharma volume, 2023-28
Table 20: Brazil Size of Population (million), 2019-23
Table 21: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 22: Brazil GDP (Current Prices, $ Billion), 2019-23
Table 23: Brazil Inflation, 2019-23
Table 24: Brazil Consumer Price Index (Absolute), 2019-23
Table 25: Brazil exchange rate, 2018-23
Table 26: China generics market value: $ million, 2018-23
Table 27: China generics market volume: % of total pharma volume, 2018-23
Table 28: China generics market geography segmentation: $ million, 2023
Table 29: China generics market value forecast: $ million, 2023-28
Table 30: China generics market volume forecast: % of total pharma volume, 2023-28
Table 31: China Size of Population (million), 2019-23
Table 32: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 33: China GDP (Current Prices, $ Billion), 2019-23
Table 34: China Inflation, 2019-23
Table 35: China Consumer Price Index (Absolute), 2019-23
Table 36: China exchange rate, 2018-23
Table 37: India generics market value: $ million, 2018-23
Table 38: India generics market volume: % of total pharma volume, 2018-23
Table 39: India generics market geography segmentation: $ million, 2023
Table 40: India generics market value forecast: $ million, 2023-28
Table 41: India generics market volume forecast: % of total pharma volume, 2023-28
Table 42: India Size of Population (million), 2019-23
Table 43: India real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 44: India GDP (Current Prices, $ Billion), 2019-23
Table 45: India Inflation, 2019-23
Table 46: India Consumer Price Index (Absolute), 2019-23
Table 47: India exchange rate, 2018-23
Table 48: Mexico generics market value: $ million, 2018-23
Table 49: Mexico generics market volume: % of total pharma volume, 2018-23
Table 50: Mexico generics market geography segmentation: $ million, 2023
Table 51: Mexico generics market value forecast: $ million, 2023-28
Table 52: Mexico generics market volume forecast: % of total pharma volume, 2023-28
Table 53: Mexico Size of Population (million), 2019-23
Table 54: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 55: Mexico GDP (Current Prices, $ Billion), 2019-23
Table 56: Mexico Inflation, 2019-23
Table 57: Mexico Consumer Price Index (Absolute), 2019-23
Table 58: Mexico exchange rate, 2018-23
Table 59: Teva Pharmaceutical Industries Ltd: key facts
Table 60: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 61: Teva Pharmaceutical Industries Ltd: Key Employees
Table 62: Viatris Inc: key facts
Table 63: Viatris Inc: Annual Financial Ratios
Table 64: Viatris Inc: Key Employees
Table 65: Sun Pharmaceutical Industries Ltd: key facts
Table 66: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 67: Sun Pharmaceutical Industries Ltd: Key Employees
Table 68: Novartis AG: key facts
Table 69: Novartis AG: Annual Financial Ratios
Table 70: Novartis AG: Key Employees
Table 71: Sandoz Group AG: key facts
Table 72: Sandoz Group AG: Key Employees
Table 73: Hikma Pharmaceuticals Plc: key facts
Table 74: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 75: Hikma Pharmaceuticals Plc: Key Employees
Table 76: Sanofi: key facts
Table 77: Sanofi: Annual Financial Ratios
Table 78: Sanofi: Key Employees
Table 79: Les Laboratoires Servier SAS: key facts
Table 80: Les Laboratoires Servier SAS: Key Employees
Table 81: Stada Arzneimittel AG: key facts
Table 82: Stada Arzneimittel AG: Key Employees
Table 83: Bayer AG: key facts
Table 84: Bayer AG: Annual Financial Ratios
Table 85: Bayer AG: Key Employees
Table 86: Bayer AG: Key Employees Continued
Table 87: Bayer AG: Key Employees Continued
Table 88: Lupin Ltd: key facts
Table 89: Lupin Ltd: Annual Financial Ratios
Table 90: Lupin Ltd: Key Employees
Table 91: Aspen Pharmacare Holdings Ltd: key facts
Table 92: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 93: Aspen Pharmacare Holdings Ltd: Key Employees
Table 94: EMS SA: key facts
Table 95: EMS SA: Key Employees
Table 96: Eurofarma Laboratorios SA: key facts
Table 97: Eurofarma Laboratorios SA: Key Employees
Table 98: Ache Laboratorios Farmaceuticos SA: key facts
Table 99: Ache Laboratorios Farmaceuticos SA: Key Employees

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us